ArticleNucleic acids research2026
Deleting the 2B domain of mycobacterial UvrD1 unmasks a latent helicase activity in vitro but effaces UvrD1 activity in nucleotide excision repair in vivo.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Mycobacterial UvrD1 is a DNA-dependent ATPase motor that participates as a monomer in nucleotide excision repair (NER). UvrD1 per se is a feeble helicase and its helicase activity is not required for NER. UvrD1, like other superfamily-1 ATPases, consists of 1A and 2A domains that engage ATP•Mg2+. The 2A domain is punctuated by an inserted 2B domain that has been proposed to either couple ATP hydrolysis to duplex unwinding or function as an autoinhibitor of unwinding that is overcome by homodimerization. Here, we designed and characterized UvrD1-∆2B, in which the entire 2B domain is internally deleted, that enabled an evaluation of the role of the 2B domain in UvrD1 function. Removal of the 2B domain elicited a gain of helicase activity, thereby implicating the 2B domain as an impediment to UvrD1's latent duplex unwinding capacity. We report that (i) UvrD1-∆2B is unable to fulfill UvrD1's role in NER; (ii) a merodiploid uvrD1+ uvrD1-∆2B strain is as defective in NER as a ∆uvrD1 strain; and (iii) inducible overexpression of uvrD1-∆2B in wild-type cells slows growth. The latter two effects of UvrD1-∆2B are eliminated by an ATPase/helicase-inactivating mutation. We surmise that unbridled UvrD1 helicase activity is detrimental to mycobacterial physiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.